Lillys triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial (TRIUMPH-1)
The ideal frequency really depends on your personal wellness goals
Endothelial dysfunction is considered a key link between AAS abuse and macrovascular disease
Key unknowns include: Long-term effects of repeated GH-axis stimulation Effects of sustained IGF-1 elevation Effects on glucose metabolism and insulin sensitivity Cardiovascular effects in higher-risk populations Immunogenicity after repeated exposure Differences between DAC and No DAC safety profiles Safety of non-pharmaceutical or poorly characterized peptide sources Why it matters: Short-term tolerability does not equal long-term safety
Long-term studies involving elderly subjects demonstrated improvements in immune system indices alongside cardiovascular, endocrine, and nervous system function
Unlike stimulant-based weight loss methods, GH-related fat reduction is achieved through metabolic optimization, not caloric restriction